NASDAQ:BSTC - BioSpecifics Technologies Corp.
$63.09
 $0.29
+0.46%
4:00PM EDT
2019-07-15
BioSpecifics Technologies Corp. is a biopharmaceutical company involved in the development of an injectable collagenase clostridium histolyticum for multiple indications. The Company has a development and license agreement with Endo Global Ventures, a Bermuda unlimited liability company (Endo Global Ventures), an affiliate of Endo International plc (Endo), for injectable collagenase for marketed indications and indications in development. Injectable collagenase clostridium histolyticum is marketed as XIAFLEX (or Xiapex in Europe). The two marketed indications involving its injectable collagenase are Dupuytren's contracture and Peyronie's disease. The other clinical indications for which its collagenase injection has been tested include keloids, hypertrophic scars, scarred tendons, glaucoma, herniated intervertebral discs, and as an adjunct to vitrectomy. The Company is evaluating its options for development of additional indications using collagenase. Read more at  reuters.com
sector:  health care
industry:  biotechnology
the data below are updated and published after 9pm EDT each trading day
  BSTC     avg for
industry  
  avg for
sector  
42 stocks weight:  114. 35   114. 77   204. 78  
42 stocks rank:  1. 30 K 1. 44 K 810. 33  
# analyst opinions:  1. 00   13. 59   13. 86  

quick ratio:  26. 94   5. 48   1. 89  
current ratio:  27. 11   5. 85   2. 40  

target price low:  85. 00   82. 72   115. 11  
target price avg:  85. 00   104. 42   138. 02  
target price high:  85. 00   130. 64   159. 47  
1-yr high:  71. 62   110. 27   142. 72  
last close:  62. 80   85. 12   126. 54  
50-day avg:  61. 40   86. 06   122. 35  
200-day avg:  62. 73   88. 76   121. 75  
1-yr low:  44. 14   69. 26   100. 63  
volume:  51. 42 K 3. 51 M 5. 53 M
50-day avg volume:  72. 74 K 3. 21 M 4. 22 M
200-day avg volume:  50. 48 K 3. 04 M 4. 75 M

1-day return:  1. 88 % -0. 30 % -1. 01 %
this week return:  4. 32 % -2. 16 % -1. 35 %
12-wk return:  -0. 62 % 3. 34 % 8. 69 %
52-wk return:  31. 96 % -1. 76 % 12. 22 %

enterprise value (EV):  364. 67 M 46. 50 B 123. 99 B
market cap:  457. 62 M 40. 77 B 109. 11 B
EBITDA:  23. 99 M 4. 33 B 8. 19 B
enterprise multiple (EV/EBITDA):  15. 20   5. 45   12. 05  
enterprise/revenue (EV/R):  10. 72   50. 46   9. 50  
total revenue:  34. 00 M 10. 21 B 40. 60 B
total debt:  0. 00   11. 27 B 17. 58 B
net income (common):  20. 49 M 2. 13 B 4. 27 B

shares outstanding:  7. 29 M 551. 08 M 1. 24 B
shares:  4. 12 M 559. 41 M 1. 22 B
shares short:  235. 96 K 11. 15 M 11. 94 M
shares short prior month:  324. 76 K 9. 31 M 11. 96 M
short ratio:  3. 11   5. 72   3. 43  
short % of float:  3. 88 % 6. 40 % 2. 65 %
total cash/share:  11. 60   11. 00   9. 23  
total cash:  84. 50 M 6. 03 B 6. 01 B
free cash flow:  20. 59 M 3. 02 B 4. 96 B
operating cash flow:  24. 65 M 3. 92 B 5. 99 B

book value:  14. 04   13. 02   27. 49  
price/book:  4. 47   4. 21   8. 80  
gross profits:  32. 96 M 7. 67 B 36. 29 B
operating margins:  69. 55 % -380. 20 % -38. 44 %
EBITDA margins:  70. 55 % 13. 59 % 23. 24 %
profit margins:  60. 27 % 10. 94 % 14. 00 %
gross margins:  100. 00 % 36. 11 % 55. 16 %

1-yr max volatility:  0. 00 % --- ---
1-yr mean volatility:  0. 00 % 1. 50 % 1. 08 %

1-yr EPS:  2. 79   2. 12   4. 26  
forward EPS:  4. 12   3. 47   7. 14  
P/E:  22. 52   2. 15   33. 17  
forward P/E:  15. 24   -4. 03   17. 60  
PE/G:  1. 63   0. 54   0. 34  
growth:  13. 77 % 263. 03 % 78. 34 %
earnings high:  0. 72   0. 91   1. 70  
earnings avg:  0. 72   0. 71   1. 58  
earnings low:  0. 72   0. 48   1. 46  
revenue high:  8. 98 M 2. 64 B 11. 26 B
revenue avg:  8. 98 M 2. 58 B 11. 09 B
revenue low:  8. 98 M 2. 54 B 10. 90 B
earnings growth:  11. 10 % 12. 29 % 31. 02 %
1-qtr earnings growth:  11. 00 % 9. 86 % 30. 39 %
return on assets:  15. 37 % -2. 31 % 5. 31 %
return on equity:  22. 27 % -82. 48 % 135. 30 %
revenue growth:  14. 70 % 262. 60 % 72. 94 %
revenue/share:  4. 68   12. 77   61. 38  

beta (1yr vs S&P500):  0. 74   1. 26   0. 91  
sharpe (1yr):  0. 91   0. 07   0. 77  

held % insiders:  26. 73 % 6. 08 % 3. 31 %
held % institutions:  61. 65 % 78. 36 % 69. 61 %

Research more with google or yahoo!
the data below are updated and re-published at 8pm EDT after each trading day

2019-07-14 : BSTC
.    145.578 =       145.578 :: --> INITIAL WEIGHT <--
.    + 2.789 =       148.367 :: earnings per-share addition
.                               --> FUNDAMENTALS <--
.    x 2.819 =        418.22 :: P/E factor
.    x 0.958 =       400.651 :: PE/G factor
.    x 1.699 =       680.777 :: beta factor
.    x 0.968 =       658.787 :: sharpe factor
.    x 4.425 =      2915.457 :: current ratio factor
.    x 1.019 =      2971.113 :: quick ratio factor
.     x 1.15 =      3415.544 :: short ratio factor
.    x 1.307 =      4462.829 :: return on assets factor
.    x 1.392 =      6213.017 :: return on equity factor
.    x 1.245 =      7732.255 :: earnings growth factor
.    x 1.297 =     10032.469 :: revenue growth factor
.    x 1.213 =     12164.803 :: EV/R factor
.    x 1.055 =     12835.723 :: price-to-book factor
.     x 1.13 =     14502.267 :: EBITDA factor
.    x 1.338 =     19407.793 :: EBITDA vs industry factor
.                               --> PERFORMANCE <--
.    x 2.114 =     41027.773 :: sector+industry 1-year gains factor
.    x 1.033 =      42398.02 :: industry 12-weeks return factor
.    x 1.305 =     55341.019 :: industry 2-weeks return factor
.     x 1.34 =     74181.774 :: company one-year gains+dividend factor
.    x 3.648 =    270592.709 :: company 13 weeks' performance factor
.    x 1.017 =    275261.142 :: 5-day avg > 50-day avg
.    x 0.997 =    274370.023 :: "drift" penalty 2 days ago
.    x 0.998 =    273777.786 :: "drift" penalty 3 days ago
.     / 1.88 =    145618.694 :: overall "drift" factor
.    x 0.917 =    133572.141 :: largest single-day jump factor
.        x 1 =    133572.141 :: volatility factor
.        x 1 =    133572.141 :: 42-day volatility factor
.    x 2.053 =    274228.057 :: notable returns + performance factor
.    x 2.071 =     567940.54 :: performance vs s&p500 factor
.    x 3.638 =   2066235.269 :: inverse volume-to-price factor
.                               --> PROJECTIONS <--
.    x 1.401 =   2894568.752 :: forward EPS factor
.    x 1.783 =   5161504.438 :: forward P/E factor
.    x 1.182 =   6103215.018 :: industry recommendation factor
.    x 1.008 =   6149894.491 :: factor historical industry gain for week 28
.   x 10.585 =  65094340.896 :: spline projection factor
.                               --> FINAL ADJUSTMENTS <--
.  quad root =        89.823 :: reduced for readability
.   + 19.475 =       109.297 :: add/subtract for investor sentiment
.    + 5.052 =       114.349 :: earnings report in 23 days
.                               --> FINAL WEIGHT <--
.                    114.349 :: FINAL WEIGHT for NASDAQ:BSTC


 


News feed RSS items generated from finance.google.com

News feed formatting by feed2js.org